obinutuzumab,venetoclax,chlorambucil
roche,abbvie
['cll14', 'cll']
uighv now becomes an independent risk factor for inferior pfs in the ven-obin arm of #cll14 optimal treatment approach for pts (esp. younger) with uighv very much up for debate! cll17 will provide great value here. #eha2023 
#Lymphoma #CLL specialist @OUHospitals
Hon. senior lecturer @UniofOxford
Low grade+elderly high grade UK NCRI grp member
UK #CLL forum exec committee 
#lymsm